Lupin Limited

BSE : 500257 | NSE : LUPIN
Industry : Pharma Drugs | ISIN : INE326A01037 | FreeFloat : 55.00% | FnO : Yes | LotSize : 850
Intellectual Capital (IC)4,453.37
Net Worth (NW)14,485.86
Intrinsic Worth (IW)18,939.24
Market Cap (MC)52,157.97
Economic Value Added165.25
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)23.51%
IC Gross Margin (EBITDA/IC)63.63%
IC Net Margin (NPT/IC)20.45%
Knowledge Turnover (Sales/IC)3.57
Market to Intrinsic Value (MC/IW)2.75
As OfIntrinsic ValueMarket Price
30 Jun 2021Rs. 417.25Rs. 1,149.10
20 Sep 2021 ---- Rs. 933.75
-17.20     -1.84%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesSell10 DMA : Rs. 974.44SellStrong Sell
KB > 50% : No50 DMA : Rs. 1,049.43
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Sep-18
C
3951.06
4181.74
780.67
515.18
441.36
268.45
242.73
Dec-18
C
4504.85
4548.29
454.97
175.21
95.44
-152.36
-130.06
Mar-19
C
4406.32
4492.82
962.51
681.73
596.21
296.37
336.59
Jun-19
C
4418.38
4490.59
933.42
616.33
530.71
303.05
377.60
Sep-19
C
4359.55
4492.92
318.79
-2.68
-89.14
-127.07
-214.23
Dec-19
C
3716.09
3769.27
235.01
-18.22
-106.82
-835.00
-891.98
Mar-20
C
3845.74
4054.34
818.00
603.74
496.36
391.29
-148.95
Jun-20
C
3527.86
3571.14
531.92
317.28
273.02
106.90
183.54
Sep-20
C
3835.00
3859.96
606.56
393.83
360.21
211.02
239.61
Dec-20
C
4017.36
4038.53
800.08
555.76
524.84
438.25
646.59
Mar-21
C
3783.10
3841.32
765.94
550.22
518.38
460.36
410.76
Jun-21
C
4270.19
4298.02
992.72
783.96
750.49
542.46
628.65
* C - Consolidated, S - Standalone